Effects of high‐dose statin on the human hepatic expression of genes involved in carbohydrate and triglyceride metabolism - Pramfalk, C.; Parini, P.; Gustafsson, U.; Sahlin, S.; Eriksson, M. (Journal of internal medicine, 2011)
Keywords: Adult; Aged; angiopoietin‐like protein 3; Atorvastatin; Atorvastatin Calcium; Biological and medical sciences; Blood Glucose - metabolism; C-Peptide - blood; Carbohydrate metabolism; Carbohydrates; Carbohydrates - blood; Cholesterol; Drug Administration Schedule; Enzymes; Female; Gene expression; Gene Expression Regulation - drug effects; General aspects; Glucokinase; Glucose; Heptanoic Acids - pharmacology; Hospitals; Humans; Hydroxymethylglutaryl-CoA reductase; Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology; Insulin; Insulin - blood; Lipids; Lipids - blood; Lipoproteins; Lipoproteins (very low density); liver; Liver - drug effects; Liver - metabolism; Male; Medical sciences; Metabolism; Middle Aged; Nutrition; Plasma levels; Pyrroles - pharmacology; Reverse Transcriptase Polymerase Chain Reaction - methods; SREBP1c; statins; Triglycerides; Triglycerides - blood; Angiopoietin; Liver; angiopoietin-like protein 3; Lipids; Hypocholesterolemic agent; Gene; HMG-CoA reductase inhibitor; SREBP1c; Genetics; Carbohydrate; High dose; Human; Digestive system; Enzyme; Enzyme inhibitor; Statin derivative; triglycerides; Metabolism; Triglyceride; Protein; Medicine; Atorvastatin; Hydroxymethylglutaryl-CoA reductase; Oxidoreductases; Antilipemic agent